DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Eren F, Kurt R, Ermis F, Atug O, Imeryuz N, Yilmaz Y.
Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease.
Clin Biochem 2012;
45 (09) 655-658
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.